Evidence map›Paper›PMID 41514675›Full record

ArticleCancers2026

Functional miRNA Transfer in Models of Serous Ovarian Carcinoma.

Goda G Muralidhar, Hilal Gurler Main, Jia Xie, Joelle S Suarez, Maria V Barbolina

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Goda G MuralidharDepartment of Pharmaceutical Sciences, University of Illinois College of Pharmacy, 833 S Wood Str., Chicago, IL 60612, USA.
Hilal Gurler MainDepartment of Pharmaceutical Sciences, University of Illinois College of Pharmacy, 833 S Wood Str., Chicago, IL 60612, USA.
Jia XieDepartment of Pharmaceutical Sciences, University of Illinois College of Pharmacy, 833 S Wood Str., Chicago, IL 60612, USA.
Joelle S SuarezDepartment of Pharmaceutical Sciences, University of Illinois College of Pharmacy, 833 S Wood Str., Chicago, IL 60612, USA.ORCID 0000-0003-1528-2701
Maria V BarbolinaDepartment of Pharmaceutical Sciences, University of Illinois College of Pharmacy, 833 S Wood Str., Chicago, IL 60612, USA.ORCID 0000-0003-0827-3508

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntracellular miRNA transfer is an intriguing and lesser-described mode of intracellular communication. Epithelial ovarian carcinoma, of which the high-grade serous histotype represents the most common and deadliest form, is characterized by a microenvironment consisting of tumor and stromal cells, ascitic fluid, and extracellular matrix, presenting a rich milieu of factors that can affect neighboring cells.

methodsWe examined the mode of miR transfer in serous ovarian carcinoma cell lines cultured on different extracellular matrix supports both in two-dimensional and three-dimensional formats coupled with traditional, live-cell time-lapse, multiphoton fluorescence imaging modalities, and fluorescence-activated cell sorting approaches.

resultsOur data demonstrate that miR can transfer between cells both in culture and in vivo. Moreover, transferred miRNA results in target-specific gene expression changes in recipient cells. Our data indicate that miR transfer occurs via extracellular vesicles, which shuttle from and within the donor and recipient cells via endocytic pathways recruiting sorting, early, late, and recycling endosomes.

conclusionsOur study highlights the phenomenon of miR transfer as a mode of communication between serous ovarian cancer cells, which can affect both treatment and diagnostics of this disease.

Indexed as

extracellular vesiclesmiRNA transferovarian cancer

Identifiers

PMID41514675
PMCPMC12784692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.